3 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment Masitinib, Placebo, Best Supportive Care - Indolent Systemic Mastocytosis | Phase 3 | Unknown | AB Science | 140 | 2020-07-01 | 2023-05-06 |
| Microneedling and Latanoprost in Acrofacial Vitiligo Latanoprost, Microneedling - Vitiligo | Phase 2 / Phase 3 | Unknown | Sohag University | 70 | 2018-09-01 | 2018-08-28 |
| Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol Sequential phototherapy, Continuous phototherapy - Vitiligo | Phase 3 | Unknown | Istituti Fisioterapici Ospitalieri | 200 | 2007-04-01 | 2010-06-02 |
Vitiligo (2) · Blushing (1) · Mastocytosis (1) · Mastocytosis, Systemic (1) · Piebaldism (1) · Pruritus (1)
Pigmentation Disorders (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Albinism (1) · Amino Acid Metabolism, Inborn Errors (1) · Behavior (1) · Communication (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Immune System Diseases (1) · Mast Cell Activation Disorders (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1)
Latanoprost (1) · Percutaneous Collagen Induction (1) · masitinib (1)
AB Science (1) · Istituti Fisioterapici Ospitalieri (1) · Sohag University (1)
France (1) · Germany (1) · Italy (1) · Netherlands (1) · Poland (1) · Romania (1) · Russia (1) · Ukraine (1) · United Kingdom (1)
Cristina Bulai Livideanu, MD, MSc (1) · Mauro Picardo, MD (1) · Ramadan Saleh, MD (1)
2016 (1)